The effect of HA digestion and HA replenishment alone or with CS on barrier function measured by TEER. by Charlotte J. van Ginkel (20790466)

“…PS decreased TEER. (C) Different treatments (treatment groups n = 8)with HA and/or CS did not affect TEER recovery after PS treatment, full recovery was seen in all groups after 24 hours. …”

Base-case results. by Ping Chen (89712)

The base case analysis. by Wenwang Lang (20293527)

“…</p><p>Results</p><p>In the base-case scenario, adding benmelstobart and anlotinib to chemotherapy increased QALYs by 0.34 at an additional cost of $24,684.07, yielding an ICER of $71,559.84 per QALY. …”

Base-case results. by Shuo Kang (1306860)

“…One-way and probabilistic sensitivity analyses were conducted to estimate the robustness of the model results,</p><p>Results</p><p>In base-case analysis, compared with toripalimab plus chemotherapy and chemotherapy alone, ITH-testing directed therapy could bring additional 0.14 QALYs and 0.29 QALYs, with marginal costs of $3750.75 and $7778.18, resulting in the ICER of $27,353.27/QALY and $26,461.46/QALY, respectively, which lower than the Chinese willingness-to-pay (WTP) threshold. …”

Base-case results. by Mingxi Xie (19812594)

“…The model time-frame was one-year. Base-case analysis and sensitivity analysis were performed. …”

Base-case analysis. by Akiko Kowada (14659965)

“…The willingness-to-pay (WTP) threshold was set at US$50,000 per QALY gained. In the base-case analysis, HTLV-1 antenatal screening (US$76.85, 24.94766 QALYs, 24.94813 LYs, ICER; US$40,100 per QALY gained) was cost-effective compared with no screening (US$2.18, 24.94580 QALYs, 24.94807 LYs). …”

Characterization and outcomes of lymphoma cases based on immunophenotype. by Heather Wilson-Robles (731578)

Distribution of proven CPA cases based on their types. by Aishwarya Selvasekhar (20529339)

The MDAE does not vary significantly for different sizes of subsampled graphs. by Niklas Smedemark-Margulies (3539957)

Statistically significant DMRs (<i>fwerArea</i> ≤ 0.05) between severe and mild SS cases located in genes previously identified as hypomethylated in cases relative to non-cases. by Calvin Chi (6240473)

Significant factors in Section A associated with the usefulness of an early warning to take timely preventive action. by Rafdzah Zaki (161810)

LAG3 deficiency enhance Th1 cells and decrease Treg upon adoptive transfer into wild-type mice followed by <i>E</i>. <i>multilocularis</i> infection. by Dewei Li (2806207)

LAG3 deficiency enhances Th1 cells and decrease Treg upon adoptive transfer into wild-type mice followed by <i>E</i>. <i>multilocularis</i> infection. by Dewei Li (2806207)

Gender-wise distribution of CHIKV cases based on ELISA and RT-PCR. by Rajendra Prasad Chatterjee (18309672)

Significant influences of forest features on relative treatment effects (ln(inside the fence/outside the fence)), i.e. lnRR. by Deborah Schäfer (6940535)

Descriptive data for the simulated population (base-case scenario). by Jacek A. Kopec (8519922)

Case and control groups based on diabetes complication indicators. by Ni Luh Putu S. P. Paramita (17061131)

ADSCs transplantation ameliorates liver fibrosis in <i>E</i>. <i>multilocularis</i> infected mice. by Ning Yang (114965)

Indicators for competitive comparative advantage and their significance. by Linhan Shao (20978182)

Subjects:

Input values and distributions used in the base case and sensitivity analysis. by Afschin Gandjour (342184)